FDA Officials Reject NDA, in Current Form, for Gastroparesis Treatment
April 3rd 2019If approved, Gimoti would be the first non-oral drug treatment for symptoms associated with acute and recurrent diabetic gastroparesis in adult women and would represent the first significant advancement in the treatment of gastroparesis in 40 years.
Read More